Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
PLoS Med. 2023 Dec 19;20(12):e1004324. doi: 10.1371/journal.pmed.1004324. eCollection 2023 Dec.
The association between assisted reproductive technologies (ARTs) and the body mass index (BMI) of children remains controversial. Confounding by morbidity and other factors associated with parental infertility may have biased studies comparing children born after ART with children born after no treatment. We investigated the associations between different fertility treatments and BMI in children at age 5 to 8 years, adjusting for and stratifying by causes of parental infertility.
This Danish cohort study included 327,301 children born between 2007 and 2012 (51% males, median age at follow-up 7 years). Of these, 13,675 were born after ART, 7,728 were born after ovulation induction with or without intrauterine insemination [OI/IUI], and 305,898 were born after no fertility treatments. Using the International Obesity Task Force (IOTF) standards, we defined overweight (BMI ≥ IOTF-25) and obesity (BMI ≥ IOTF-30). We compared children born after ART versus OI/IUI; intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilization (IVF); and frozen-thawed versus fresh embryo transfer and estimated crude and adjusted prevalences of children with overweight or obesity at age 5 to 8 years, prevalence odds ratios (PORs), and differences in mean BMI z-scores. Adjustment was performed using stabilized inverse probability of treatment weights, including parity, year of conception, parental causes of infertility, age, educational level, comorbidities, maternal country of origin, BMI, and smoking as covariates. The crude prevalence of obesity was 1.9% in children born after ART, 2.0% in those born after OI/IUI, and 2.7% in those born after no fertility treatment. After adjustment, children born after ART and OI/IUI had the same prevalence of being overweight (11%; POR 1.00, 95% confidence interval [CI] 0.91 to 1.11; p = 0.95) or obese (1.9%; POR 1.01, 95% CI 0.79 to 1.29; p = 0.94). Comparison of ICSI with conventional IVF yielded similar pattern (POR 0.95, 95% CI 0.83 to 1.07; p = 0.39 for overweight and POR 1.16, 95% CI 0.84 to 1.61; p = 0.36 for obesity). Obesity was more prevalent after frozen-thawed (2.7%) than fresh embryo transfer (1.8%) (POR 1.54, 95% CI 1.09 to 2.17; p = 0.01). The associations between fertility treatments and BMI were only modestly different in subgroups defined by the cause of infertility. Study limitations include potential residual confounding, restriction to live births, and lack of detailed technical information about the IVF procedures.
We found no association with BMI at age 5 to 8 years when comparing ART versus OI/IUI or when comparing ICSI versus conventional IVF. However, use of frozen-thawed embryo transfer was associated with a 1.5-fold increased risk of obesity compared to fresh embryo transfer. Despite an elevated relative risk, the absolute risk difference was low.
辅助生殖技术(ART)与儿童体重指数(BMI)之间的关联仍存在争议。与父母不孕相关的发病率和其他因素的混杂可能会使比较接受 ART 治疗后出生的儿童与未接受治疗后出生的儿童的研究产生偏倚。我们调查了不同的生育治疗方法与 5 至 8 岁儿童 BMI 之间的关联,调整了父母不孕的原因,并对其进行了分层。
这是一项丹麦队列研究,共纳入了 327301 名 2007 年至 2012 年出生的儿童(51%为男性,随访时的中位年龄为 7 岁)。其中,13675 名儿童是通过 ART 出生的,7728 名儿童是通过排卵诱导加或不加宫腔内人工授精(OI/IUI)出生的,305898 名儿童是通过没有生育治疗出生的。我们使用国际肥胖问题工作组(IOTF)标准,将超重(BMI≥IOTF-25)和肥胖(BMI≥IOTF-30)定义为。我们比较了接受 ART 治疗与 OI/IUI 治疗的儿童;ICSI 与常规体外受精(IVF);以及冷冻-解冻胚胎与新鲜胚胎移植,并估计了 5 至 8 岁儿童超重或肥胖的发生率、患病比值比(POR)以及平均 BMI z 评分的差异。采用稳定的逆概率治疗权重进行调整,包括胎次、受孕年份、父母不孕的原因、年龄、教育程度、合并症、母亲原籍国、BMI 和吸烟等协变量。ART 治疗后儿童肥胖的粗患病率为 1.9%,OI/IUI 治疗后儿童肥胖的粗患病率为 2.0%,无生育治疗后儿童肥胖的粗患病率为 2.7%。调整后,接受 ART 和 OI/IUI 治疗的儿童超重的患病率相同(11%;POR 1.00,95%置信区间[CI]0.91 至 1.11;p=0.95)或肥胖(1.9%;POR 1.01,95%CI 0.79 至 1.29;p=0.94)。ICSI 与常规 IVF 的比较也得出了类似的结果(POR 0.95,95%CI 0.83 至 1.07;p=0.39 超重和 POR 1.16,95%CI 0.84 至 1.61;p=0.36 肥胖)。冷冻-解冻胚胎移植(2.7%)的肥胖发生率高于新鲜胚胎移植(1.8%)(POR 1.54,95%CI 1.09 至 2.17;p=0.01)。根据不孕原因的不同,生育治疗与 BMI 之间的关联在亚组之间的差异仅略有不同。研究的局限性包括潜在的残余混杂、限制活产以及缺乏关于 IVF 程序的详细技术信息。
我们发现,在比较 ART 与 OI/IUI 或比较 ICSI 与常规 IVF 时,BMI 与年龄在 5 至 8 岁之间没有关联。然而,与新鲜胚胎移植相比,使用冷冻-解冻胚胎移植与肥胖的风险增加 1.5 倍相关。尽管相对风险升高,但绝对风险差异很小。